|
|
||||||||||||||||||||||||||||||||||||||||||||
By The Online Investor Staff, updated Mon., May. 20, 10:46 AM
|
|||||||||||||||||||||||||||||||||||||||||||||
Secondary Stock Offerings| This Slide: #6 of 25 |
Slide #6. Rockwell Medical, Inc. — Secondary Offering
Company:
Rockwell Medical, Inc. (NASDAQ:RMTI)
Date announced:
5/15/2013
Shares Offered:
11,475,410
Date of Pricing:
5/15/2013
Price Per Share:
$3.05
Secondary Offering Details:
Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis, announced today that it has priced an underwritten public offering of 11,475,410 shares of its common stock at a price to the public of $3.05 per share for gross proceeds of $35.0 million. The net proceeds from the sale of the shares, after deducting the underwriters' discounts and other estimated offering expenses payable by Rockwell, will be approximately $32.8 million. Rockwell has also granted the underwriters a 30-day option to purchase up to an additional 1,721,312 shares of common stock offered in the public offering to cover overallotments, if any.
Rockwell Medical manufactures, sells and distributes hemodialysis concentrates, comprising of two primary product types, acidified dialysate concentrate or acid concentrate and bicarbonate. Co.'s products include: Renal Pure® and CitraPure® Liquid Acid Concentrate, Dri-Sate® Dry Acid Concentrate and Mixing System, RenalPure® Powder Bicarbonate Concentrate, and SteriLyte® Liquid Bicarbonate Concentrate. Co. also provides ancillary products including blood tubing, fistula needles, custom kits, cleaning agents, and filtration salts to hemodialysis providers. Co. has licensed a drug therapy, soluble ferric pyrophosphate, for the delivery of iron supplementation for anemic dialysis patients.
Open the RMTI Page at The Online Investor »
|
||||||||||||||||||
Open the RMTI Page at The Online Investor (in a new window) »
|
Trade RMTI Now: |
Avg. Broker Rec.
 
|
Buy (2.67 out of 4) 36th percentile
(ranked lower than approx. 64% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
Secondary Stock Offerings | www.TheOnlineInvestor.com | Copyright © 1998 - 2013, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.